Full Press Release Details
Country Healthcare Announces Second Quarter 2016 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--August 3, 2016--Cross Country
Healthcare, Inc. (Nasdaq: CCRN) today announced financial results for
the second quarter ended June 30, 2016.
Revenue was $199.4 million compared to $192.6 million, up 4%
Adjusted EBITDA was $11.1 million, or 5.5% of revenue versus $8.2
million, or 4.2% of revenue in the prior year, up 35% year-over-year
Adjusted EPS was $0.16 compared to $0.10 in the prior year
GAAP net loss was $17.2 million, or $0.54 per diluted share,
including non-cash impairment charges and a loss on derivative
Cash flow from operations was $10.3 million compared to $5.7
million in the prior year
Note: Refer to table and discussion of Non-GAAP financial measures below.
"For the second quarter this year, we again exceeded guidance for Gross
Profit and Adjusted EBITDA Margins driven by strong pricing and leverage
from revenue growth," said William J. Grubbs, President and Chief
Executive Officer. "The market remains robust and supports our
initiatives aimed at accelerating revenue growth as we progress
throughout the year."
Second quarter consolidated revenue was $199.4 million, an increase of
4% year-over-year and 1% sequentially. The Company's consolidated gross
profit margin was 27.5%, up 240 basis points year-over-year and up 150
basis points sequentially. Adjusted EBITDA was $11.1 million or 5.5% of
revenue, as compared with $8.2 million or 4.2% of revenue in the prior
year. Net loss attributable to common shareholders was $17.2 million
compared to net income of $2.6 million in the prior year, primarily due
to impairment charges related to Physician Staffing, loss on derivative
liability and loss on extinguishment of debt. Diluted EPS was a net loss
of $0.54 per share compared to net income of $0.08 per share in the
prior year. Adjusted EPS was $0.16 compared to $0.10 in the prior year
and $0.09 in the prior quarter.
For the six months ended June 30, 2016, consolidated revenue was $396.0
million, an increase of 5% year-over-year. Consolidated gross profit
margin was 26.7%, up 150 basis points year-over-year. Adjusted EBITDA
was $19.6 million or 4.9% of revenue, as compared with $14.3 million or
3.8% of revenue in the prior year. Net income attributable to common
shareholders was $1.8 million, or a net loss of $0.26 per diluted share,
compared to net income of $5.5 million, or $0.13 per diluted share, in
the prior year. Adjusted EPS was $0.25 compared to $0.12 in the prior
Quarterly Business Segment Highlights
Nurse and Allied Staffing
Revenue from Nurse and Allied Staffing was $172.0 million and increased
13% year-over-year and 2% sequentially. Contribution income in this
segment was $17.6 million, up from $12.8 million in the prior year. The
year-over-year increase in segment revenue and contribution income was
due to improved pricing and the impact of the Mediscan acquisition.
Average field FTEs increased to 6,884 from 6,607 in the prior year.
Revenue per FTE per day was $275 compared to $254 in the prior year,
reflecting higher average bill rates.
Revenue from Physician Staffing was $23.9 million and decreased 20%
year-over-year and 2% sequentially, entirely due to a decrease in
volume. Contribution income was $2.1 million, down from $2.2 million in
the prior year. Compared to the prior year, total days filled decreased
to 14,480 from 20,282 while revenue per day filled increased to $1,525
from $1,468 due to improved pricing.
Other Human Capital Management Services
Revenue from Other Human Capital Management Services was $3.5 million, a
decrease of 66% year-over-year and an increase of 3% sequentially. The
year-over-year decrease was primarily the result of the divestiture of
the education seminars business in August 2015. Revenue from our
physician and executive search business decreased 20%, compared to the
prior year. Contribution income was $0.1 million, compared to $0.7
million in the prior year.
Cash Flow and Balance Sheet Highlights
Cash flow provided by operating activities was $10.3 million compared to
$5.7 million in the same period of the prior year. During the second
quarter of 2016, we entered into a new $140 million senior credit
agreement that provides for a $40 million term loan and a revolving
credit facility of up to $100 million (together the "Facilities"). The
Facilities replace both the Company's senior secured asset-based
revolving credit facility and its subordinated term loan. Proceeds from
the $40 million term loan were used primarily to refinance existing
indebtedness under the asset-based revolving credit facility and the
subordinated term loan, including prepayment fees and interest, as well
as fees and expenses incurred.
At June 30, 2016, the Company had $10.2 million in cash and cash
equivalents, $40 million of term loan and $25 million of convertible
notes at par. There were no borrowings drawn on its $100 million
revolving credit facility, and $23.1 million of letters of credit
outstanding, leaving $76.9 million available for borrowings under the
revolving credit facility.
Outlook for Third Quarter and Full Year 2016
| Q3 2016 Range | Year-over-Year | |||
| Change | ||||
| Revenue | $200 million - $205 million | 2% - 5% | ||
| Gross profit margin | 26.7% - 27.2% | 40 - 90 bps | ||
| Adjusted EBITDA margin | 5.0% -5.5% | (130) - (80) bps | ||
| Adjusted EPS | $0.13 - $0.15 | $(0.10) - $(0.08) | ||
| FY 2016 Range | Year-over-Year | |||
| Change | ||||
| Revenue | $800 million - $815 million | 4% - 6% | ||
| Adjusted EBITDA margin | 5.5% - 6.0% | 60 - 110 bps |
The estimates above are based on current management expectations and, as
such, are forward-looking and actual results may differ materially.
These ranges do not include the potential impact of any future
divestitures, mergers, acquisitions or other business combinations, any
impairment charges or valuation allowances, any acquisition-related
measurement period adjustments, or any material legal or restructuring
INVITATION TO CONFERENCE CALL
The Company will hold its quarterly conference call on Thursday,
August 4, 2016, at 9:00 A.M. Eastern Time to discuss its second quarter
2016 financial results. This call will be webcast live and can be
accessed at the Company's website at www.crosscountryhealthcare.com
or by dialing 800-857-6331 from anywhere in the U.S. or by dialing
517-623-4781 from non-U.S. locations - Passcode: Cross Country. A replay
of the webcast will be available from August 4th through August 18th at
the Company's website and a replay of the conference call will be
available by telephone by calling 800-395-7443 from anywhere in the U.S.
or 203-369-3271 from non-U.S. locations - Passcode: 2016.